文献速递妇科

趋化因子CXCL12及其受体CXCR4在子宫腺肌病中的表达与意义

[Expression and significance of chemokine CXCL12 and receptor CXCR4 in adenomyosis].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2020-01-01

该研究纳入38例子宫腺肌病患者和31例对照,采用免疫组化和实时荧光定量PCR检测子宫内膜及肌层中CXCL12、CXCR4的蛋白和mRNA表达。结果显示腺肌病组各组织CXCL12、CXCR4表达均显著高于对照组(P均<0.05),且两者在子宫内膜和肌层中呈正相关(r=0.478、0.542)。提示CXCL12/CXCR4可能协同参与子宫腺肌病发生发展。

要点

  • 子宫腺肌病子宫内膜和肌层中CXCL12、CXCR4蛋白及mRNA表达均升高。
  • 腺肌病组CXCL12与CXCR4 mRNA在子宫内膜和肌层中呈正相关(r=0.478、0.542)。
  • CXCL12/CXCR4可能协同参与子宫腺肌病的发生发展。

核心结论

  • 子宫腺肌病子宫内膜和肌层组织中CXCL12、CXCR4表达增加且呈正相关,两种因子可能协同参与疾病发生发展。

研究设计与样本

  • 选取2017年10月至2018年12月于首都医科大学附属北京妇产医院因子宫腺肌病行子宫切除术的患者38例作为腺肌病组,同期因宫颈上皮内瘤变Ⅲ级或宫颈癌行子宫切除术的患者31例作为对照组。
  • 采用免疫组化二步法和实时荧光定量PCR检测两组子宫内膜和子宫肌层组织中CXCL12、CXCR4的蛋白和mRNA表达水平,并分析两者表达相关性。

主要发现

  • CXCL12和CXCR4蛋白在腺肌病组子宫内膜中的表达分别为0.229±0.025、0.226±0.016,高于对照组的0.153±0.018、0.178±0.026,差异均有统计学意义(P均<0.05)。
  • CXCL12和CXCR4蛋白在腺肌病组子宫肌层中的表达分别为0.222±0.045、0.126±0.058,高于对照组的0.091±0.029、0.099±0.020,差异均有统计学意义(P均<0.05)。
  • CXCL12和CXCR4 mRNA在腺肌病组子宫内膜中的表达分别为6.31±0.12、8.49±0.21,高于对照组的1.23±0.10、1.36±0.13,差异均有统计学意义(P均<0.05)。
  • CXCL12和CXCR4 mRNA在腺肌病组子宫肌层中的表达分别为9.11±0.12、8.45±0.16,高于对照组的1.18±0.08、1.46±0.13,差异均有统计学意义(P均<0.05)。
  • 腺肌病组中CXCL12与CXCR4 mRNA在子宫内膜和子宫肌层中的表达呈线性正相关(r=0.478、0.542,P均<0.05)。

临床怎么用

  • CXCL12/CXCR4表达升高与正相关提示其可能作为子宫腺肌病发病机制研究的候选通路。
  • 该发现尚属机制探索,不能直接用于临床诊断或治疗决策。

局限性

  • 对照组为宫颈上皮内瘤变Ⅲ级或宫颈癌患者,非健康子宫,可能影响比较。
  • 样本量有限(腺肌病组38例、对照组31例),为单中心研究。
  • 仅检测表达与相关性,未进行功能实验验证因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To observe the expression, correlation and significance of chemokine (C-X-C motif) ligand 12 (CXCL12) and chemokine (C-X-C motif) receptor 4 (CXCR4) in endometrium and myometrium of adenomyosis. Methods: Totally 38 patients were selected in this study, who underwent hysterectomy for adenomyosis at Beijing Obstetrics and Gynecology Hospital from October 2017 to December 2018 as the adenomyosis group, and, in the same period, selected 31 patients with cervical intraepithelial neoplasia Ⅲ or cervical cancer undergoing hysterectomy served as control group. The expression levels of mRNA and protein for CXCL12, CXCR4 in the endometrium and myometrium of the two groups were detected by immunohistochemistry and real-time PCR. Results: (1) The protein levels of CXCL12 and CXCR4 in endometrium in uterus with adenomyosis (0.229±0.025 and 0.226±0.016) were significantly higher than those in endometrium in uterus without adenomyosis (0.153±0.018 and 0.178±0.026); compared with each other, the differences were statistically significant (all P<0.05). And the expressions of CXCL12 and CXCR4 proteins in uterine myometrium of adenomyosis were 0.222±0.045 and 0.126±0.058, respectively, which were higher than those in the control group (0.091±0.029 and 0.099±0.020); compared with each other, the differences were statistically significant (all P<0.05). (2) The expression levels of CXCL12 and CXCR4 mRNA in endometrium of patients with adenomyosis were 6.31±0.12 and 8.49±0.21, respectively, which were higher than those in the control group (1.23±0.10 and 1.36±0.13); compared with each other, the differences were statistically significant (all P<0.05). Moreover, the expression levels of CXCL12 and CXCR4 mRNA in myometrium of patients with adenomyosis were 9.11±0.12 and 8.45±0.16, respectively, which were higher than those in the control group (1.18±0.08 and 1.46±0.13); compared with each other, the differences were statistically significant (all P<0.05). (3) In endometrium and myometrium of uterus with adenomyosis, CXCL12 and CXCR4 mRNA expression levels were positively associated (r=0.478, 0.542, all P<0.05). Conclusions: The levels of CXCL12 and CXCR4 in the endometrium and myometrium of adenomyosis are increased and positively correlated. The two chemokine may be involved in the development of adenomyosis. 目的: 观察子宫腺肌病(AM)子宫内膜和子宫肌层中CXC型趋化因子配体12(CXCL12)及CXC型趋化因子受体4(CXCR4)的表达、相关性和意义。 方法: 选取2017年10月至2018年12月于首都医科大学附属北京妇产医院,因AM行子宫切除术的患者38例作为AM组,选择同期因子宫颈上皮内瘤变Ⅲ级或子宫颈癌行子宫切除术的患者31例作为对照组,通过免疫组化二步法和实时荧光定量PCR技术检测两组患者子宫内膜和子宫肌层组织中CXCL12、CXCR4 mRNA和蛋白的表达水平,并分析CXCL12与CXCR4表达的相关性。 结果: (1)CXCL12和CXCR4蛋白在AM组子宫内膜组织中的表达水平分别为0.229±0.025、0.226±0.016,显著高于对照组的0.153±0.018、0.178±0.026,分别比较,差异均有统计学意义(P均<0.05);CXCL12和CXCR4蛋白在AM组子宫肌层组织中的表达水平分别为0.222±0.045、0.126±0.058,显著高于对照组的0.091±0.029、0.099±0.020,分别比较,差异均有统计学意义(P均<0.05)。(2)CXCL12和CXCR4 mRNA在AM组子宫内膜组织中的表达水平分别为6.31±0.12、8.49±0.21,显著高于对照组的1.23±0.10、1.36±0.13,分别比较,差异均有统计学意义(P均<0.05);CXCL12和CXCR4 mRNA在AM组子宫肌层组织中的表达水平分别为9.11±0.12、8.45±0.16,显著高于对照组的1.18±0.08、1.46±0.13,分别比较,差异均有统计学意义(P均<0.05)。(3)AM组中CXCL12与CXCR4 mRNA在子宫内膜和子宫肌层组织中的表达呈线性正相关关系(r=0.478、0.542,P均<0.05)。 结论: AM子宫内膜和子宫肌层组织中CXCL12、CXCR4的表达增加且呈正相关,两种因子可能协同作用参与AM的发生、发展。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang S, Duan H, Li BH, et al. [Expression and significance of chemokine CXCL12 and receptor CXCR4 in adenomyosis]. Zhonghua Fu Chan Ke Za Zhi. 2020. PMID: 33228346. doi:10.3760/cma.j.cn112141-20200226-00140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。